At BioClonal, we are developing a new generation of antibodies targeting highly challenging and disease-relevant structures in Alzheimer’s disease.
Solving the Complexity of
anti-peptide Antibodies
Next-Generation
Alzheimer Antibodies
Our proprietary, peptide-focused immunization strategy and ‘Superimmunogen’ design systematically converts low-immunogenic peptides into reliable antibody targets. Access highly validated research tools primed for neurodegenerative discovery.
Retention
Clinical assays & platforms for early detection of neurological indicators.
Expertise
Specialized in anti-peptide antibodies against low-immunogenic and structurally complex targets.
Rigorous Validation
Rigorous in vitro assay validation complete. High-affinity binding to target dimers with near-zero cross-reactivity.
Focused on what matters
in Alzheimer’s
antibodies available for immediate deployment.
INVENTORY FOCUS
Our catalog is specifically designed around peptide targets involved in Alzheimer’s disease, including Tau and Amyloid-beta related epitopes.
PRODUCT CODE
PROGRAM
TARGET AREA
FORMAT
STATUS
BCL-KL-001
KL PROGRAM
Peptide-based target
Monoclonal antibody
AVAILABLE / UNDER VALIDATION
BCL-KL-002
KL PROGRAM
Peptide-based target
Monoclonal antibody
AVAILABLE / UNDER VALIDATION
BCL-KL-003
KL PROGRAM
Peptide-based target
Monoclonal antibody
AVAILABLE / UNDER VALIDATION
BCL-KL-004
KL PROGRAM
Peptide-based target
Monoclonal antibody
AVAILABLE / UNDER VALIDATION
BCL-AD-021
ALZHEIMER PROGRAM
Modified Aβ related target
Monoclonal antibody
Validation ongoing
BCL-AD-022
ALZHEIMER PROGRAM
Modified Aβ related target
Monoclonal antibody
VALIDATION ONGOING
BCL-INS-001
INSULIN PROGRAM
INSULIN TARGET
Monoclonal antibody
AVAILABLE / UNDER VALIDATION
Engineered Precision:
Drugging the Unstable Epitope
Tangible results achieved through our conformational targeting expertise.
VALIDATION STATUS
Rigorous In Vitro Assay Complet
We isolate and target the specific toxic Aβ1-42 dimers—the true neurotoxic drivers of pathology—avoiding inefficient generic amyloid clearance.
SELECTIVITY
Precision
OFF-TARGET
Minimized
IP RISK
Zero
Looking for a
specific antibody?
Contact us for custom development services or additional targets not listed in our current catalog.
We specialize in specific Tau and Amyloid-beta related epitopes.
Partnerships
TechnicalFAQs
«Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
«Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
«Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.